Roc vs. Sux - The CURASMUR Trial

February 18, 2020 00:19:11
Roc vs. Sux - The CURASMUR Trial
Critical Care Perspectives in Emergency Medicine
Roc vs. Sux - The CURASMUR Trial

Feb 18 2020 | 00:19:11

/

Show Notes

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation!

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

August 24, 2017 00:25:06
Episode Cover

Hyponatremic Encephalopathy

Hyponatremia is one of the most common electrolyte disorders encountered in emergency medicine and critical care.  Patients with hyponatremic encephalopathy represent a severe form...

Listen

Episode 0

March 19, 2019 00:18:13
Episode Cover

BMV for ETI in the Critically Ill?

More than 1.5 million patients undergo endotracheal intubation each year in the U.S.  Endotracheal intubation can be complicated by hypoxemia, which is a known...

Listen

Episode 0

October 04, 2022 00:25:21
Episode Cover

Does a Restrictive Oxygenation Target Make a Difference in the Post-Arrest Patient?

The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require...

Listen